[144] Jazz Pharmaceuticals, Inc. SEC Filing
Form 144 notice for Jazz Pharmaceuticals (JAZZ) reports a proposed sale of 3,731 common shares on NASDAQ with an aggregate market value of $417,872. The form lists total shares outstanding as 60,658,809 and an approximate sale date of 08/08/2025.
The shares were acquired on 08/07/2025 through restricted stock vesting from the issuer and the form records payment/compensation as of 08/07/2025. ETRADE FINANCIAL CORPORATION is named as the broker. The filer indicates no securities sold in the past three months and attests they are not aware of undisclosed material adverse information about the issuer.
Avviso del modulo 144 per Jazz Pharmaceuticals (JAZZ) segnala la proposta di vendita di 3,731 azioni ordinarie su NASDAQ per un valore complessivo di $417,872. Il modulo indica il totale delle azioni in circolazione pari a 60,658,809 e una data approssimativa di vendita il 08/08/2025.
Le azioni sono state acquisite il 08/07/2025 tramite il vesting di azioni soggette a restrizioni dall'emittente e il modulo registra il pagamento/compenso in data 08/07/2025. Come broker 猫 indicata ETRADE FINANCIAL CORPORATION. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e attesta di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Aviso del formulario 144 para Jazz Pharmaceuticals (JAZZ) informa de una propuesta de venta de 3,731 acciones ordinarias en NASDAQ por un valor agregado de $417,872. El formulario se帽ala un total de acciones en circulaci贸n de 60,658,809 y una fecha aproximada de venta el 08/08/2025.
Las acciones fueron adquiridas el 08/07/2025 mediante el vesting de acciones restringidas por parte del emisor y el formulario registra el pago/compensaci贸n con fecha 08/07/2025. Se nombra como intermediario a ETRADE FINANCIAL CORPORATION. El declarante indica no haber vendido valores en los 煤ltimos tres meses y declara no tener conocimiento de informaci贸n adversa material no divulgada sobre el emisor.
Jazz Pharmaceuticals (JAZZ) 甏�霠� Form 144 韱奠电� NASDAQ鞐愳劀 齑濎暋 $417,872鞐� 頃措嫻頃樀鐢 3,731 氤错喌欤� 毵り皝 鞓堨爼鞚� 氤搓碃霅橃棃鞚岇潉 鞎岆雼堧嫟. 鞏戩嫕鞐惖鐢 氚滍枆 欤检嫕 齑濎垬 60,658,809瓿� 鞓堨儊 毵り皝鞚� 08/08/2025鞚� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 欤检嫕鞚� 08/07/2025鞐� 氚滍枆靷攵�韯� 鞝滍暅攵� 欤检嫕鞚� 氩犾姢韺�(惫别蝉迟颈苍驳)鞙茧 旆摑霅橃棃鞙茧┌, 鞏戩嫕鞐惖鐢 歆�旮�/氤挫儊鞚检澊 08/07/2025搿� 旮半霅橃柎 鞛堨姷雼堧嫟. 欷戧皽鞚胳溂搿湹鐢 ETRADE FINANCIAL CORPORATION鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 歆�雮� 靹� 雼� 霃欖晥 歃濌秾鞚� 韺愲Г頃橃 鞎婌晿鞚�鞚� 氚濏瀳瓿�, 氚滍枆靷棎 甏�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞛堧嫟瓿� 鞚胳頃橁碃 鞛堨 鞎婌潓鞚� 歆勳垹頃╇媹雼�.
Avis du formulaire 144 pour Jazz Pharmaceuticals (JAZZ) signale une proposition de vente de 3,731 actions ordinaires sur le NASDAQ pour une valeur totale de $417,872. Le formulaire indique le nombre total d'actions en circulation 脿 60,658,809 et une date approximative de vente le 08/08/2025.
Les actions ont 茅t茅 acquises le 08/07/2025 par vesting d'actions restreintes 茅mises par l'茅metteur et le formulaire enregistre le paiement/r茅mun茅ration au 08/07/2025. Le courtier d茅sign茅 est ETRADE FINANCIAL CORPORATION. Le d茅clarant indique aucune vente de titres au cours des trois derniers mois et atteste ne pas 锚tre au courant d'informations d茅favorables importantes non divulgu茅es concernant l'茅metteur.
Formular 144-Mitteilung f眉r Jazz Pharmaceuticals (JAZZ) meldet einen geplanten Verkauf von 3,731 Stammaktien an der NASDAQ mit einem Gesamtmarktwert von $417,872. Das Formular nennt die Gesamtzahl der ausstehenden Aktien mit 60,658,809 und ein ungef盲hres Verkaufsdatum 08/08/2025.
Die Aktien wurden am 08/07/2025 durch das Vesting eingeschr盲nkter Aktien vom Emittenten erworben, und das Formular vermerkt die Zahlung/Verg眉tung zum 08/07/2025. Als Broker ist ETRADE FINANCIAL CORPORATION angegeben. Der Einreichende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und versichert, ihm seien keine nicht offengelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt.
- None.
- None.
Insights
TL;DR: Routine small insider sale of newly vested restricted shares; unlikely to move market or indicate material change.
The notice documents a proposed disposition of 3,731 shares valued at $417,872, acquired by restricted stock vesting the day before the planned sale. With 60,658,809 shares outstanding recorded on the form and no reported sales in the prior three months, this filing appears operational and compensation-driven rather than a signal of company-specific problems. Disclosure follows Rule 144 mechanics and includes the broker designation.
TL;DR: Disclosure is consistent with Rule 144 requirements; attestation included and transaction recorded as compensation.
The form indicates the shares resulted from restricted stock vesting and that payment was recorded as compensation. The filer鈥檚 attestation that they do not possess undisclosed material information is present on the form. Broker information is provided. There are no reported prior sales in the past three months, suggesting this is a routine reporting of an insider compensation event.
Avviso del modulo 144 per Jazz Pharmaceuticals (JAZZ) segnala la proposta di vendita di 3,731 azioni ordinarie su NASDAQ per un valore complessivo di $417,872. Il modulo indica il totale delle azioni in circolazione pari a 60,658,809 e una data approssimativa di vendita il 08/08/2025.
Le azioni sono state acquisite il 08/07/2025 tramite il vesting di azioni soggette a restrizioni dall'emittente e il modulo registra il pagamento/compenso in data 08/07/2025. Come broker 猫 indicata ETRADE FINANCIAL CORPORATION. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e attesta di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Aviso del formulario 144 para Jazz Pharmaceuticals (JAZZ) informa de una propuesta de venta de 3,731 acciones ordinarias en NASDAQ por un valor agregado de $417,872. El formulario se帽ala un total de acciones en circulaci贸n de 60,658,809 y una fecha aproximada de venta el 08/08/2025.
Las acciones fueron adquiridas el 08/07/2025 mediante el vesting de acciones restringidas por parte del emisor y el formulario registra el pago/compensaci贸n con fecha 08/07/2025. Se nombra como intermediario a ETRADE FINANCIAL CORPORATION. El declarante indica no haber vendido valores en los 煤ltimos tres meses y declara no tener conocimiento de informaci贸n adversa material no divulgada sobre el emisor.
Jazz Pharmaceuticals (JAZZ) 甏�霠� Form 144 韱奠电� NASDAQ鞐愳劀 齑濎暋 $417,872鞐� 頃措嫻頃樀鐢 3,731 氤错喌欤� 毵り皝 鞓堨爼鞚� 氤搓碃霅橃棃鞚岇潉 鞎岆雼堧嫟. 鞏戩嫕鞐惖鐢 氚滍枆 欤检嫕 齑濎垬 60,658,809瓿� 鞓堨儊 毵り皝鞚� 08/08/2025鞚� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 欤检嫕鞚� 08/07/2025鞐� 氚滍枆靷攵�韯� 鞝滍暅攵� 欤检嫕鞚� 氩犾姢韺�(惫别蝉迟颈苍驳)鞙茧 旆摑霅橃棃鞙茧┌, 鞏戩嫕鞐惖鐢 歆�旮�/氤挫儊鞚检澊 08/07/2025搿� 旮半霅橃柎 鞛堨姷雼堧嫟. 欷戧皽鞚胳溂搿湹鐢 ETRADE FINANCIAL CORPORATION鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 歆�雮� 靹� 雼� 霃欖晥 歃濌秾鞚� 韺愲Г頃橃 鞎婌晿鞚�鞚� 氚濏瀳瓿�, 氚滍枆靷棎 甏�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞛堧嫟瓿� 鞚胳頃橁碃 鞛堨 鞎婌潓鞚� 歆勳垹頃╇媹雼�.
Avis du formulaire 144 pour Jazz Pharmaceuticals (JAZZ) signale une proposition de vente de 3,731 actions ordinaires sur le NASDAQ pour une valeur totale de $417,872. Le formulaire indique le nombre total d'actions en circulation 脿 60,658,809 et une date approximative de vente le 08/08/2025.
Les actions ont 茅t茅 acquises le 08/07/2025 par vesting d'actions restreintes 茅mises par l'茅metteur et le formulaire enregistre le paiement/r茅mun茅ration au 08/07/2025. Le courtier d茅sign茅 est ETRADE FINANCIAL CORPORATION. Le d茅clarant indique aucune vente de titres au cours des trois derniers mois et atteste ne pas 锚tre au courant d'informations d茅favorables importantes non divulgu茅es concernant l'茅metteur.
Formular 144-Mitteilung f眉r Jazz Pharmaceuticals (JAZZ) meldet einen geplanten Verkauf von 3,731 Stammaktien an der NASDAQ mit einem Gesamtmarktwert von $417,872. Das Formular nennt die Gesamtzahl der ausstehenden Aktien mit 60,658,809 und ein ungef盲hres Verkaufsdatum 08/08/2025.
Die Aktien wurden am 08/07/2025 durch das Vesting eingeschr盲nkter Aktien vom Emittenten erworben, und das Formular vermerkt die Zahlung/Verg眉tung zum 08/07/2025. Als Broker ist ETRADE FINANCIAL CORPORATION angegeben. Der Einreichende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und versichert, ihm seien keine nicht offengelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt.
FAQ
What does the JAZZ Form 144 report?
When were the shares acquired according to the filing?
Who is the broker listed on the Form 144 for JAZZ?
Has the filer sold other securities of JAZZ in the past three months?
How many JAZZ shares are outstanding according to the form?
